Amlodipine
Amlodipine is a medication used to treat high blood pressure and chest pain by relaxing blood vessels, which helps lower blood pressure and allows more oxygen-rich blood to reach the heart. Studies have found that amlodipine effectively lowers blood pressure through its action as a calcium channel blocker, which prevents calcium from entering certain muscle cells of the heart and blood vessels, leading to relaxation and widening of the arteries. Research also shows it can be combined with other medications like valsartan or olmesartan for enhanced effectiveness in managing hypertension.
Amlodipine connects strongly with conditions such as hypertension and angina, as well as with other drugs used in combination therapy for blood pressure management. While amlodipine is widely studied, the evidence primarily comes from studies that focus on its pharmacological properties rather than large-scale clinical outcomes.
Sources
- Amlodipine: an overview of its pharmacodynamic and pharmacokinetic properties. (PMID:9156957)
- Amlodipine besylate. (PMID:22469316)
- [[Amlodipine].](https://pubmed.ncbi.nlm.nih.gov/1830707/) (PMID:1830707)
- Amlodipine/Valsartan: fixed-dose combination in hypertension. (PMID:18257612)
- Olmesartan medoxomil/amlodipine. (PMID:19405551)
- Amlodipine: a new calcium antagonist. (PMID:8135260)
_Worker-drafted node, Hermes writer enrichment, pending editorial review._
Connections
No connections recorded yet.
Sources
- Amlodipine: an overview of its pharmacodynamic and pharmacokinetic properties. (1994) pubmed
- Amlodipine besylate. (2012) pubmed
- [Amlodipine]. (1991) pubmed
- Amlodipine/Valsartan: fixed-dose combination in hypertension. (2008) pubmed
- Olmesartan medoxomil/amlodipine. (2009) pubmed
- Amlodipine: a new calcium antagonist. (1994) pubmed
- Perindopril/amlodipine (Prestalia(®)): a review in hypertension. (2015) pubmed
- Telmisartan/amlodipine: single-pill combination in hypertension. (2010) pubmed
- Amlodipine: a pharmacoeconomic review. (2009) pubmed
- Amlodipine versus Angiotensin-receptor blockers for nonhypertension indications. (2002) pubmed